ePrints

Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism

Lookup NU author(s): Dr Richard Quinton

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2021 John Wiley & Sons Ltd.Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its diagnosis and management exist. There are several current guidelines on testosterone replacement therapy that have been driven predominantly by single disciplines. The Society for Endocrinology commissioned this new guideline to provide all care providers with a multidisciplinary approach to treating patients with MH. This guideline has been compiled using expertise from endocrine (medical and nursing), primary care, clinical biochemistry, urology and reproductive medicine practices. These guidelines also provide a patient perspective to help clinicians best manage MH.

Publication metadata

Author(s): Jayasena C, Anderson RA, Llahana S, Barth J, MacKenzie F, Wilkes S, Smith ND, Sooriakumaran P, Minhas S, Wu FCW, Tomlinson JW, Quinton R

Publication type: Article

Publication status: Published

Journal: Clinical Endocrinology

Year: 2022

Volume: 96

Issue: 2

Pages: 200-219

Print publication date: 01/02/2022

Online publication date: 22/11/2021

Acceptance date: 28/10/2021

ISSN (print): 0300-0664

ISSN (electronic): 1365-2265

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1111/cen.14633

DOI: 10.1111/cen.14633

Altmetrics

Share